| Literature DB >> 29214599 |
Bing Tian Zhao1,2, Duc Hung Nguyen1, Duc Dat Le1, Jae Sue Choi3, Byung Sun Min1, Mi Hee Woo4.
Abstract
Since PTP1B enzyme was discovered in 1988, it has captured the research community's attention. This landmark discovery has stimulated numerous research studies on a variety of human diseases, including cancer, inflammation, and diabetes. Tremendous progress has been made in finding PTP1B inhibitors and exploring PTP1B regulatory mechanisms. This review investigates for the natural PTP1B inhibitors, and focuses on the common characteristics of the discovered structures and structure-activity relationships. To facilitate understanding, all the natural compounds are here divided into five different classes (fatty acids, phenolics, terpenoids, steroids, and alkaloids), according to their skeletons. These PTP1B inhibitors of scaffold structures could serve as a theoretical basis for new concept drug discovery and design.Entities:
Keywords: Chemical structure; Natural sources; PTP1B inhibitors; Structure–activity relationships
Mesh:
Substances:
Year: 2017 PMID: 29214599 DOI: 10.1007/s12272-017-0997-8
Source DB: PubMed Journal: Arch Pharm Res ISSN: 0253-6269 Impact factor: 4.946